New treatments for common cardiovascular risk factor near the market, with billions at stake My colleague @DrewQJoseph takes a look at the race to develop drugs targeting Lp(a) — $NVS $AMGN and $LLY

Role of Exercise in Cardiovascular Disease and Alzheimer's Disease Comorbidity: A Blood Biomarker Perspective "..the impact and application of different exercise modalities in this comorbidity, concluding with suitable exercise prescriptions and relevant safety considerations for each modality..." @Cells_MDPI @MDPIOpenAccess

Resistance training is cardiovascular medicine for postmenopausal women. It reduces resting heart rate, blood pressure, and even improves measures of artery stiffness and endothelial function in women aged 52-78. Reminder that it's not just aerobic exercise that's good for the heart!

Herpes zoster vaccine effectiveness against cardiovascular events - a systematic literature review and meta-analysis "HZ vaccination (ZVL or RZV) was associated with a significantly lower rate of CV events. The potential cardioprotective effect of HZ vaccination could help to further reduce disease burden in adults, warranting further research."

Trial of 8,000+ people finds cardiovascular drug fails to cut heart attacks and strokes, leaving a key longevity risk unresolved. #longevity# #geroscience# #cardiovascular# #heartattack# #stroke# @Novartis